Stockhub

significant drug interaction English (P769)

WikibaseProperty Discussion
Revision as of 11:57, 4 August 2022 by imported>Nzechimere (‎Added [ig] description: Mmekọrịta dị ịrịba ama na ụlọ ọgwụ n'etiti ihe abụọ na-arụ ọrụ ọgwụ na-emepụta ọgwụ (ya bụ, ọgwụ na / ma ọ bụ metabolites na-arụ ọrụ) ebe oriri concomitant nwere ike iduga ngbanwe nke ọma ma ọ bụ ọgwụ ọjọọ ev.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
clinically significant interaction between two pharmacologically active substances (i.e., drugs and/or active metabolites) where concomitant intake can lead to altered effectiveness or adverse drug events. English
edit
Language Label Description Also known as
British English
No label defined
No description defined

    Data type

    Item

    Statements

    instance of
    Q19887775 (Deleted Item)
    0 references
    subject item of this property
    Q718753 (Deleted Item)
    0 references
    Wikidata property example
    Q407431 (Deleted Item)
    significant drug interaction English
    Q417740 (Deleted Item)
    0 references
    property usage tracking category English
    Q26249998 (Deleted Item)
    0 references
    property constraint
    Q21503250 (Deleted Item)
    class
    pharmaceutical drug
    relation English
    Q30208840 (Deleted Item)
    0 references
    Q21503247 (Deleted Item)
    property
    DrugBank ID English
    0 references
    Q21510865 (Deleted Item)
    class
    pharmaceutical drug
    relation English
    Q30208840 (Deleted Item)
    0 references
    Q21510864 (Deleted Item)
    property
    DrugBank ID English
    0 references
    Q53869507 (Deleted Item)
    constraint status English
    Q21502408 (Deleted Item)
    property scope English
    Q54828448 (Deleted Item)
    0 references
    Retrieved from ‘https://stockhub.co/index.php?title=WikibaseProperty:P769&oldid=104036’